CME

CME


Clinician’s Update on Omega-3s in ASCVD Risk Reduction

July 15, 2021

Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE

Guest: Leslie Cho, MD

More than 15 professional societies now recommend the use of icosapent ethyl to treat atherosclerotic cardiovascular disease (ASCVD), but clinical questions about the use of ome